雪鹰领主,最好看的小说排行,有声读物

趨化因子C-X-C-基元受體4(CXCR4)重組抗體

Recombinant Antibody to Chemokine C-X-C-Motif Receptor 4 (CXCR4)

CD184; Fusin; NPYR; HSY3RR; LAP3; LCR1; LESTR; NPY3R; NPYRL; WHIM; Leukocyte-derived seven transmembrane domain receptor; Lipopolysaccharide-associated protein 3

編號RAA940Hu21
物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 所有
- 人
- 小鼠
- 大鼠
- 豚鼠
- 家兔
- 獼猴
- 山羊
- 綿羊
- 馬
- 牛
- 豬
- 雞
- 狗
- 其他物種
- 多物種
- 泛物種
來源重組單抗制備
宿主小鼠
效價(jià)(克隆號)-
Ig亞型 IgG
純化方式抗原特異性親和純化
標(biāo)記物無標(biāo)記物
免疫原 -
緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
性狀液體
濃度1mg/mL
且適物種-
應(yīng)用WB; IF; ICC; IHC; IP; FCM.
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。
下載英文說明書中文說明書
規(guī)格 20μl100μl 200μl 1ml 10ml
價(jià)格 ¥ 810 1890 ¥ 1890 ¥ 2700 ¥ 6750 ¥ 27000
欲了解實(shí)際交易價(jià)格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!

產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)

Human Jurkat cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 5μg/ml mouse Anti-human CXCR4 Recombinant Antibody (Catalog RAA940Hu21, red histogram) or Isotype control antibody (Catalog IS067-Mu03, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).

通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對CXCR4的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別CXCR4。

用法

Western blotting: 0.2-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Flow cytometry:5μg/ml;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。

贈品

增值服務(wù)

抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
 細(xì)胞和組織染色液
 抗體陽性對照品
 組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
 DAB顯色試劑盒
 SABC試劑盒
 長臂生物素標(biāo)記試劑盒
 小鼠抗體可變區(qū)基因擴(kuò)增試劑盒
 實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)

相關(guān)產(chǎn)品

編號	適用物種：Homo sapiens (Human，人)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPA940Hu01	趨化因子C-X-C-基元受體4(CXCR4)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
CPA940Hu21	趨化因子C-X-C-基元受體4(CXCR4)卵白蛋白偶聯(lián)物	Immunogen; SDS-PAGE; WB.
PAA940Hu08	趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體	WB; IHC; ICC; IP.
PAA940Hu01	趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體	WB; IHC; ICC; IP.
FAA940Hu01	抗趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體	Flow cytometry.
FAA940Hu41	抗趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體(藻紅素標(biāo)記)	Flow cytometry.
FAA940Hu51	抗趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體(別藻藍(lán)蛋白標(biāo)記)	Flow cytometry.
FAA940Hu81	抗趨化因子C-X-C-基元受體4(CXCR4)多克隆抗體(異硫氰酸熒光素標(biāo)記)	Flow cytometry.
MAA940Hu21	趨化因子C-X-C-基元受體4(CXCR4)單克隆抗體	WB; IHC; ICC; IP.
MAA940Hu22	趨化因子C-X-C-基元受體4(CXCR4)單克隆抗體	WB; IHC; ICC; IP.
RAA940Hu21	趨化因子C-X-C-基元受體4(CXCR4)重組抗體	WB; IF; ICC; IHC; IP; FCM.
SEA940Hu	趨化因子C-X-C-基元受體4(CXCR4)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)	Enzyme-linked immunosorbent assay for Antigen Detection.
LMA940Hu	趨化因子C-X-C-基元受體4(CXCR4)等多因子檢測試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志	參考文獻(xiàn)
International Journal of Cancer	Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model [Wiley: source]
Plos one	Emodin Suppresses Migration and Invasion through the Modulation of CXCR4 Expression in an Orthotopic Model of Human Hepatocellular Carcinoma [PubMed: PMC3589458]
Atherosclerosis	The non-alcoholic fraction of beer increases stromal cell derived factor 1 and the number of circulating endothelial progenitor cells in high cardiovascular risk subjects: A randomized clinical trial [Pubmed:24530788]
Pharmacol Rep.?	Comparison of chemokines (CCL-5 and SDF-1), chemokine receptors (CCR-5 and CXCR-4) and IL-6 levels in patients with different severities of depression [Pubmed:25150002]
Pharmacological Reports	Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality disorder [PubMed: 26481549]
Pharmacological Reports	A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity [Pubmed:27208878]
BMC Cancer.?	Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists [pmc:PMC4866076]
Frontiers in Bioengineering and Biotechnology	Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison?… [Pubmed:29670878]

留言咨詢